How Will Emyria’s Medibank-Backed Clinic Transform Mental Health Care in Victoria?
Emyria has secured expanded funding from Medibank to support its Treatment-Resistant Depression and PTSD programs at a new clinic in Victoria, marking a significant step in its national mental health care rollout.
- Medibank expands funding for Emyria’s Mornington Peninsula clinic
- First insurer-backed mental health programs launched in Victoria
- Programs target Treatment-Resistant Depression and PTSD patients
- Positive 12-month clinical data supports national scaling strategy
- Expansion complements existing sites in Western Australia and Queensland
Emyria’s Victorian Expansion Backed by Medibank
Emyria Limited (ASX – EMD), a pioneer in mental health treatment delivery, has announced an expanded funding agreement with Medibank Private Ltd (ASX – MPL) to support its new Mornington Peninsula clinic in Victoria. This development marks Emyria’s first insurer-backed mental health program in the state, complementing its existing operations in Western Australia and Queensland.
The funding arrangement enables eligible Medibank customers to access Emyria’s Empax Clinic programs, which focus on Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD). Delivered within a licensed hospital environment, these psychiatrist-led, psychotherapy-based programs aim to reduce financial barriers for patients with complex mental health needs.
Addressing Australia’s Mental Health Treatment Gaps
With nearly half of Australians expected to experience a mental health condition during their lifetime, TRD and PTSD represent some of the most challenging disorders to treat effectively. Access to specialist, multidisciplinary care has traditionally been fragmented and costly, often accompanied by long wait times.
Emyria’s collaboration with Medibank seeks to bridge this gap by integrating insurer-backed funding with hospital-based programs. This approach not only facilitates timely access to evidence-based treatments but also reduces out-of-pocket expenses for patients, a critical factor in improving mental health outcomes.
Clinical Evidence Underpins Growth Strategy
Recent positive 12-month durability data from Emyria’s PTSD program reinforce the effectiveness and sustainability of its Empax treatment model. These results provide growing clinical validation that the company’s integrated care pathways deliver lasting benefits for patients with complex and treatment-resistant mental health conditions.
By combining real-world data collection with insurer funding and clinical delivery, Emyria is positioning itself as a scalable platform capable of national adoption. The Mornington Peninsula clinic, set to commence operations in the second quarter of 2026, is a key milestone in this strategy.
Looking Ahead – National Rollout and Market Implications
Emyria’s Executive Chairman, Greg Hutchinson, highlighted the significance of the Victorian expansion, stating that integrating insurer funding into high-quality hospital programs removes longstanding financial barriers and broadens access to comprehensive mental health treatments. With funded programs now active across three states, Emyria is demonstrating the scalability of its data-driven care model.
As demand for measurable, outcomes-driven mental health care grows, Emyria’s partnership with Medibank and its ongoing national rollout could reshape how complex mental health conditions are treated across Australia.
Bottom Line?
Emyria’s insurer-backed expansion into Victoria signals a new phase of scalable, accessible mental health care across Australia.
Questions in the middle?
- How quickly will patient enrollment ramp up at the Mornington Peninsula clinic?
- What financial impact will the expanded Medibank funding have on Emyria’s revenue?
- When will the pending Authorised Prescriber applications be approved to enable full operations?
